From Research labs to the Bedside: 4th Generation DNA Sequencing to Guide the UAE into Good Health
With genetics and genetics in charge of an individual's day-to-day state of health and predisposition to develop disease, the capacity to take genomics from the lab bench in hi-tech laboratories actually to the client's bedside will play a very important function in the future of the health of clients across the UAE. Delegates at the MEDLAB Exhibition & Congress, the world's leading occasion for lab administration and diagnostics, which proceeds until 9th February at the Dubai International Convention & Exhibit Centre, today spoke with Dr PK Menon, Director, Lab Providers, GMC Diagnostics, Ajman, UAE, about the immense potential of 4th generation DNA sequencing to cure genetically inherited conditions, among others.
To comprehend genetics, we should study the sequence of nucleic acids which comprise the genetics. This is called DNA sequencing. Today, with Fourth generation sequencing, it ends up being very easy to review large amounts of hereditary material in a short span of time. The Fourth generation sequencers are very tiny, the size of a matchbox, and they work with a laptop and do their data evaluations in the cloud. Inning accordance with Dr Menon, this new disruptive modern technology will, in the next few years, change how we understand genes and allow us to really take genomics from the research laboratory to the client's bedside.
" For example, throughout the Ebola outbreak in Africa, under field problems, utilizing the Fourth generation sequencer, scientists could, within one and a fifty percent hours of the sample being separated, acquire the sequences of the Ebola infection in the African countryside. Therefore, this is mosting likely to alter the method diagnostics are going to occur," described Dr Menon. "Likewise, in microbiology, germs's genetics could be swiftly determined for bacterial resistance aspects to anti-biotics and thus assist make quick decisions on appropriate treatment for the person."
As in much of the rest of the world, there are numerous labs in the UAE that execute First and Second generation sequencing, creating large quantities of information over a longer period of time. However, the Centre for Biomedical Study and Innovation at the Gulf Medical University in Ajman has actually gotten the first 4th generation sequencer in the region where they are intending to introduce and bring in more recent analysis capacities permitting patients to get their outcomes much faster.
According to Dr Menon, "Our genes determine just what a person is mosting likely to resemble, what metabolic diseases they might struggle with and the feasible cancers which could create if the person does not lead a healthy life. DNA-based screening is gaining value in the region and, in the times ahead, a growing number of individuals will certainly utilize DNA sequencing as a device in accuracy medicine to assist themselves into anticipating positive health."
Carlo Kaabar CEO of Futurelab Medical Laboratories and Co-Chair of the Lab Monitoring meeting at the congress, explained exactly how lowered prices in technology is making sophisticated hereditary screening available to the region:
Technology has now come down in rate from millions 20 years back, to actually being able to do a genome (gene) examination for $1,000. Rather than laboratories simply reporting an examination's result and value, they will certainly currently have the ability to really tell individuals their genetic make-up. That is no doubt influencing what the future research laboratory is mosting likely to look like and it was exciting to hear the conversations at this conference, especially from the local research laboratory community that are introducing this testing which will clearly benefit people in the UAE", he claimed.
Over the four-day show, MEDLAB Congress offers over 11 CME-accredited multi-disciplinary seminar tracks including topics such as lab management, molecular diagnostics and professional chemistry. Tomorrow's programme will certainly showcase the much-awaited topics such as the influence of increasing Point-of-Care Testing (POCT) from a hospital-based setup to the community, along with the function of the lab in professional info and the concern of whether individuals ought to have accessibility to their lab examination outcomes.
The exhibition will certainly likewise continue to see ground-breaking products on program, such as innovative diapers that assist screen the existence of ketons and sugar in the baby's pee from house, along with a macro digital imaging system that permits pathologists to rapidly and properly document specimens from surgical procedures while lowering specimen summary time and enhancing performance and workflow. In addition, site visitors will certainly likewise be provided the possibility to receive a hands-on training on some of the most up to date technologies by exhibitors.
Simon Page, Managing Director of Informa Life Sciences Exhibitions, the organisers of MEDLAB stated: "The scientific programme at MEDLAB has been thoroughly made to clarify the interesting new technologies utilised in today's medical labs that could have a real impact on enhancing the health and health and wellbeing of people throughout the region. We delight in to be able to combine several of the world's brightest minds in the field to work together to present a few of the pioneering options to this part of the world."
As a platform for the leaders busy industry to showcase their latest updates and innovation, MEDLAB additionally organizes greater than 700 of the world's leading lab monitoring and diagnostics brands such as Abbott, Siemens Healthineers, Snibe Diagnostic, Beckman Coulter and much more.
To find out more concerning MEDLAB Exhibition & Congress 2017, please see www.medlabme.com
